The use of the nondepolarizing neuromuscular blocking drug cis-atracurium in dogs

Veterinary Anaesthesia and Analgesia

Volumn 28, Issue 3, 2001, Pages 156-160

  Adams, Wendy A ^a   Robinson, Kerry J ^a   Mark Senior, J ^a   Jones, Ronald S ^a  

^a School of Anaesthesia   (United Kingdom)

Author keywords

Cis atracurium; Dogs; Neuromuscular blockade

Indexed keywords

EID: 84950117991     PISSN: 14672987     EISSN: 14672995     Source Type: Journal    
DOI: 10.1046/j.1467-2987.2001.00045.x     Document Type: Article

References (15)

1. Belmont MR, Lien CA, Quessy S, et al. (1995) The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 82, 1139–1145.pmid/7741288
2. Boyd AH, Eastwood NB, Parker CJR, et al. (1996) Comparison of the pharmacodynamics and pharmocokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 76, 382–388.pmid/8785138
3. Cullen LK, Jones RS, Snowden SL (1980) Neuromuscular activity in the intact dog: techniques for recording evoked mechanical responses. Br Vet J 136, 154–159.pmid/7397470
4. De Wolf AM, Freeman JA, Scott VL, et al. (1996) Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 76, 624–628.pmid/8688259
5. Eastwood NB, Boyd AH, Parker CJR, et al. (1995) Pharmocokinetics of 1R-cis 1'R-cis-atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 75, 431–435.pmid/7488483
6. Hennis PJ, Fahey MR, Canfell PC, et al. (1986) Pharmacology of laudanosine in dogs. Anesthesiology 65, 56–60.pmid/3729058
7. Hughes R (1986) Atracurium: an overview. Br J Anaesth 58(Suppl.), 2–5.
8. Hunter JM, Eastwood NB, Boyd AH, et al. (1995) Pharmacokinetics of 51W89: preliminary data. Acta Anaesthesiol Scand 106 (Suppl.), 94.
9. Jones RS & Clutton RE (1984) Clinical observations on the use of the muscle relaxant atracurium in the dog. J Small Anim Pract 325, 473–477.
10. Jones RS, Hunter JM, Utting JE (1983) Neuromuscular blocking action of atracurium in the dog and its reversal by neostigmine. Res Vet Sci 34, 173–176.pmid/6687951
11. Kisor DF, Schmith VD, Wargin WA, et al. (1996) Importance of organ-independent elimination of cisatracurium. Anesth Analg 83, 1065–1071.pmid/8895287
12. Martinez EA, Hartsfield SM, Carroll GL, et al. (2000) Neuromuscular effects of cisatracurium in anesthetized dogs. Vet Anaesth Analg 27, 101–102.
13. Parker CJR & Hunter JM (1989) Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 62, 177–183.pmid/2923767
14. Wastila WB, Maehr RB, Turner GL, et al. (1996) Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology 85, 169–177.pmid/8694363
15. Watkins J (1986) Histamine release and atracurium. Br J Anaesth 58(Suppl.), 19–22.